ALEXANDER CORCORAN: Open Payments
NPI 1215211628 · BELHAVEN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 32 payments from 13 companies in 2025. Trend: 2023 $368 · 2024 $397 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 2 | $149 |
| Abbott Laboratories | 6 | $111 |
| Novo Nordisk Inc | 6 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Corcept Therapeutics | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| ABBVIE INC. | 3 | $48 |
| Amgen Inc. | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| PFIZER INC. | 1 | $15 |
Products named: CLEVIPREX, FREESTYLE LIBRE 2, XIFAXAN, Korlym, Wegovy, VRAYLAR, AIRSUPRA, Ozempic.
Industry payments across NC — which companies pay providers there.
